SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CME Group Inc. – ‘10-Q’ for 9/30/23 – ‘EX-31.1’

On:  Wednesday, 11/1/23, at 2:56pm ET   ·   For:  9/30/23   ·   Accession #:  1156375-23-190   ·   File #:  1-31553

Previous ‘10-Q’:  ‘10-Q’ on 8/2/23 for 6/30/23   ·   Next & Latest:  ‘10-Q’ on 5/1/24 for 3/31/24   ·   1 Reference:  By:  CME Group Inc. – ‘10-K’ on 2/28/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/01/23  CME Group Inc.                    10-Q        9/30/23   64:6.4M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.44M 
 2: EX-10.1     Equity Grant Letter Performance Shares              HTML     44K 
 3: EX-31.1     Section 302 Certification                           HTML     22K 
 4: EX-31.2     Section 302 Certification                           HTML     22K 
 5: EX-32.1     Section 906 Certification                           HTML     21K 
11: R1          Cover                                               HTML     77K 
12: R2          Consolidated Balance Sheets                         HTML    125K 
13: R3          Consolidated Balance Sheets (Parenthetical)         HTML     54K 
14: R4          Consolidated Statements Of Income                   HTML    114K 
15: R5          Consolidated Statements of Comprehensive Income     HTML     78K 
16: R6          Consolidated Statements Of Shareholders' Equity     HTML    112K 
17: R7          Consolidated Statements Of Shareholders' Equity     HTML     20K 
                (Parenthetical)                                                  
18: R8          Consolidated Statements Of Cash Flows               HTML    123K 
19: R9          Basis Of Presentation                               HTML     23K 
20: R10         Revenue Recognition (Notes)                         HTML     68K 
21: R11         Performance Bonds and Guaranty Fund Contributions   HTML     26K 
                (Notes)                                                          
22: R12         Intangible Assets And Goodwill                      HTML     80K 
23: R13         Debt                                                HTML     45K 
24: R14         Contingencies                                       HTML     26K 
25: R15         Leases (Notes)                                      HTML     88K 
26: R16         Guarantees                                          HTML     26K 
27: R17         Accumulated Other Comprehensive Income (Notes)      HTML     60K 
28: R18         Fair Value Measurements                             HTML     53K 
29: R19         Earnings Per Share                                  HTML     55K 
30: R20         Subsequent Events (Notes)                           HTML     21K 
31: R21         Revenue Recognition (Tables)                        HTML     60K 
32: R22         Intangible Assets And Goodwill (Tables)             HTML     86K 
33: R23         Debt (Tables)                                       HTML     48K 
34: R24         Leases (Tables)                                     HTML     95K 
35: R25         Accumulated Other Comprehensive Income (Tables)     HTML     59K 
36: R26         Fair Value Measurements (Tables)                    HTML     49K 
37: R27         Earnings Per Share (Tables)                         HTML     55K 
38: R28         Revenue Recognition (Details)                       HTML     20K 
39: R29         Revenue Recognition Disaggregation of Revenue       HTML     60K 
                (Details)                                                        
40: R30         Performance Bonds and Guaranty Fund Contributions   HTML     48K 
                (Details)                                                        
41: R31         Intangible Assets And Goodwill (Narrative)          HTML     21K 
                (Details)                                                        
42: R32         Intangible Assets And Goodwill (Components Of       HTML     46K 
                Intangible Assets) (Details)                                     
43: R33         Intangible Assets And Goodwill (Future Estimated    HTML     33K 
                Amortization Expense) (Details)                                  
44: R34         Intangible Assets And Goodwill (Components of       HTML     40K 
                Goodwill) (Details)                                              
45: R35         Debt (Schedule Of Short-Term And Long-Term Debt)    HTML     66K 
                (Details)                                                        
46: R36         Debt (Schedule Of Maturities Of Long-Term Debt)     HTML     35K 
                (Details)                                                        
47: R37         Leases (Details)                                    HTML     24K 
48: R38         Leases Lease Costs (Details)                        HTML     34K 
49: R39         Leases Supplemental Cash Flow Information-Leases    HTML     23K 
                (Details)                                                        
50: R40         Leases Supplemental Balance Sheet                   HTML     43K 
                Information-Leases (Details)                                     
51: R41         Leases Operating Leases Future Minimum Payments     HTML     39K 
                (Details)                                                        
52: R42         Leases Capital Leases, Future Minimum Payments Due  HTML     39K 
                (Details)                                                        
53: R43         Guarantees (Details)                                HTML     35K 
54: R44         Accumulated Other Comprehensive Income (Details)    HTML     60K 
55: R45         Fair Value Measurements (Narrative) (Details)       HTML     23K 
56: R46         Fair Value Measurements (Financial Instruments      HTML     49K 
                Measured At Fair Value On A Recurring Basis)                     
                (Details)                                                        
57: R47         Fair Value Measurements (Estimated Fair Values of   HTML     45K 
                Long-Term Debt) (Details)                                        
58: R48         Earnings Per Share (Narrative) (Details)            HTML     24K 
59: R49         Earnings Per Share (Net Income Attributable To CME  HTML     50K 
                Group) (Details)                                                 
62: XML         IDEA XML File -- Filing Summary                      XML    111K 
60: XML         XBRL Instance -- cme-20230930_htm                    XML   1.54M 
61: EXCEL       IDEA Workbook of Financial Report Info              XLSX    101K 
 7: EX-101.CAL  XBRL Calculations -- cme-20230930_cal                XML    142K 
 8: EX-101.DEF  XBRL Definitions -- cme-20230930_def                 XML    490K 
 9: EX-101.LAB  XBRL Labels -- cme-20230930_lab                      XML   1.26M 
10: EX-101.PRE  XBRL Presentations -- cme-20230930_pre               XML    743K 
 6: EX-101.SCH  XBRL Schema -- cme-20230930                          XSD    125K 
63: JSON        XBRL Instance as JSON Data -- MetaLinks              405±   589K 
64: ZIP         XBRL Zipped Folder -- 0001156375-23-000190-xbrl      Zip    276K 


‘EX-31.1’   —   Section 302 Certification


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 31.1
CERTIFICATION
I, Terrence A. Duffy, certify that:
    1. I have reviewed this report on Form 10-Q of CME Group Inc.;
    2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
    3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
    4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
    a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
    b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
    c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
    d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
    5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
    a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
    b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: November 1, 2023/s/ Terrence A. Duffy
Name: Terrence A. Duffy
Title: Chief Executive Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/1/234
For Period end:9/30/23
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  CME Group Inc.                    10-K       12/31/23  107:11M
Top
Filing Submission 0001156375-23-000190   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 7:53:01.1am ET